Weather
Program
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

166.42 +2.07 (+1.26%)
Official Closing Price Updated: 7:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,176,748
Open 165.39
Bid (Size) 166.01 (6)
Ask (Size) 167.90 (1)
Prev. Close 164.35
Today's Range 164.49 - 166.49
52wk Range 130.96 - 182.89
Shares Outstanding N/A
Dividend Yield 3.56%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine,... 
Via Benzinga
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts
Via Benzinga

Performance

YTD
+4.13%
+4.13%
1 Month
+1.32%
+1.32%
3 Month
-6.24%
-6.24%
6 Month
+20.33%
+20.33%
1 Year
+16.02%
+16.02%

More News

Read More
7 Value Stocks to Buy and Hold for a Decade of Dominance
Via InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
Via Benzinga
Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
Topics Retirement
Exposures Pension
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Via Benzinga
Topics Cannabis
Exposures Cannabis
Unpacking the Latest Options Trading Trends in AbbVie
Via Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
Via Benzinga
3 Magnificent Stocks That Are Passive Income Machines
Via The Motley Fool
What Is the Dividend Payout for AbbVie Stock?
Via The Motley Fool
Healthcare And Biotech Investing 101: What You Need To Know.
Via Talk Markets
Topics Stocks
Exposures US Equities
Earn $1000 Every Month From These 3 Stocks
Via The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
Via The Motley Fool
3 Reasons to Buy AbbVie Stock on the Dip
Via The Motley Fool
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,100 Today
Via Benzinga
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
Via Benzinga
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Via InvestorPlace
AbbVie Tracking for New Highs in 2024
Via MarketBeat
Topics Earnings
Exposures Financial
3 Biotech Stocks to Double Your Money in the Next 24 Months
Via InvestorPlace
MarketBeat Week in Review – 4/29 - 5/3
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns
Via InvestorPlace
Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock Higher
Via MarketBeat
Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing
Via InvestorPlace
Topics Economy
Exposures Interest Rates
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.